APA (7th ed.) Citation

(2023). Tocilizumab, a cutting-edge therapeutic resource against SARS-CoV-2 infection: A scoping review.

Chicago Style (17th ed.) Citation

Tocilizumab, a Cutting-edge Therapeutic Resource Against SARS-CoV-2 Infection: A Scoping Review. 2023.

MLA (8th ed.) Citation

Tocilizumab, a Cutting-edge Therapeutic Resource Against SARS-CoV-2 Infection: A Scoping Review. 2023.

Warning: These citations may not always be 100% accurate.